BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9489915)

  • 1. Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto.
    Riegler G; D'Incà R; Sturniolo GC; Corrao G; Del Vecchio Blanco C; Di Leo V; Carratù R; Ingrosso M; Pelli MA; Morini S; Valpiani D; Cantarini D; Usai P; Papi C; Caprilli R
    Scand J Gastroenterol; 1998 Jan; 33(1):93-8. PubMed ID: 9489915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary complications in chronic inflammatory bowel disease.
    Sciot R; Desmet VJ
    Acta Gastroenterol Belg; 1987; 50(3):299-305. PubMed ID: 3326383
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.
    Gizard E; Ford AC; Bronowicki JP; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2014 Jul; 40(1):3-15. PubMed ID: 24815622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatobiliary diseases in Crohn disease and ulcerative colitis].
    Lock G; Holstege A; Rath H; Schölmerich J
    Z Arztl Fortbild (Jena); 1994 Jun; 88(5-6):373-80. PubMed ID: 8091806
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees.
    Saubermann LJ; Deneau M; Falcone RA; Murray KF; Ali S; Kohli R; Ekong UD; Valentino PL; Grossman AB; Rand EB; Jonas MM; Saeed SA; Kamath BM
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):639-652. PubMed ID: 27984347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver and bile duct disorders in patients with ulcerative colitis and Crohn's disease].
    Bronkhorst FB; Brandt KH; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1982 Aug; 126(32):1455-8. PubMed ID: 7133185
    [No Abstract]   [Full Text] [Related]  

  • 7. Extraintestinal manifestations of idiopathic inflammatory bowel disease.
    Danzi JT
    Arch Intern Med; 1988 Feb; 148(2):297-302. PubMed ID: 3277559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver dysfunction in inflammatory bowel disease.
    Br Med J; 1979 Sep; 2(6192):688-9. PubMed ID: 509062
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease.
    Wewer V; Gluud C; Schlichting P; Burcharth F; Binder V
    Scand J Gastroenterol; 1991 Jan; 26(1):97-102. PubMed ID: 2006402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center.
    Bargiggia S; Maconi G; Elli M; Molteni P; Ardizzone S; Parente F; Todaro I; Greco S; Manzionna G; Bianchi Porro G
    J Clin Gastroenterol; 2003; 36(5):417-20. PubMed ID: 12702985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of hepatic dysfunction in inflammatory bowel disease.
    Dew MJ; Thompson H; Allan RN
    Q J Med; 1979 Jan; 48(189):113-35. PubMed ID: 482586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The liver and bilary tract in inflammatory bowel disease (author's transl)].
    Pariente EA
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1120-31. PubMed ID: 7319208
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatobiliary disorders in inflammatory bowel disease.
    Christophi C; Hughes ER
    Surg Gynecol Obstet; 1985 Feb; 160(2):187-93. PubMed ID: 3881836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.
    Nóbrega VG; Silva INN; Brito BS; Silva J; Silva MCMD; Santana GO
    Arq Gastroenterol; 2018; 55(3):290-295. PubMed ID: 30540094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary complications of inflammatory bowel disease.
    Williams SM; Harned RK
    Radiol Clin North Am; 1987 Jan; 25(1):175-88. PubMed ID: 3547468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis associated with inflammatory bowel disease in Cape Town, 1975 - 1981.
    Tobias R; Wright JP; Kottler RE; Bornman PC; Price SK; Hatfield A; Marks IN
    S Afr Med J; 1983 Feb; 63(7):229-35. PubMed ID: 6823639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory intestinal disease and its complications in primary care].
    Sánchez Hernández A; Contreras Sánchez P; Herráez García J
    Aten Primaria; 2002 May; 29(8):522. PubMed ID: 12031229
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic complications of inflammatory bowel disease.
    Baillie J; Soltis RD
    Geriatrics; 1985 Feb; 40(2):53-6, 59-60. PubMed ID: 3881318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver damage in juvenile inflammatory bowel disease.
    Nemeth A; Ejderhamn J; Glaumann H; Strandvik B
    Liver; 1990 Aug; 10(4):239-48. PubMed ID: 2215095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.